U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07077395) titled 'Finding Links Between Hot flASHes and CardioVascular Disease' on July 11.
Brief Summary: The goal of this clinical trial is to learn if drug fezolinetant improves blood vessel health in women with moderate to severe hot flashes. The main questions it aims to answer are:
Does drug fezolinetant improve blood vessel health?
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Menopause-related Hot Flashes
Intervention:
DRUG: fezolinetant - reference formulation
fezolinetant 45 mg daily x 12 weeks
DRUG: placebo
placebo daily x 12 weeks
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Massachusetts General Hospit...